JBCHEPHARM Investments vs Dividends Paid Analysis

JBCHEPHARM

1,591 11.80 0.75%

JB Chemicals financial indicator trend analysis is infinitely more than just investigating JB Chemicals Pharmac recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether JB Chemicals Pharmac is a good investment. Please check the relationship between JB Chemicals Investments and its Dividends Paid accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in JB Chemicals Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

Investments vs Dividends Paid

Investments vs Dividends Paid Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of JB Chemicals Pharmac Investments account and Dividends Paid. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between JB Chemicals' Investments and Dividends Paid is -0.11. Overlapping area represents the amount of variation of Investments that can explain the historical movement of Dividends Paid in the same time period over historical financial statements of JB Chemicals Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of JB Chemicals' Investments and Dividends Paid is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Investments of JB Chemicals Pharmaceuticals are associated (or correlated) with its Dividends Paid. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Dividends Paid has no effect on the direction of Investments i.e., JB Chemicals' Investments and Dividends Paid go up and down completely randomly.

Correlation Coefficient

-0.11

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Investments

Securities or assets acquired for generating income or appreciating in value, not used in daily operations.

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Most indicators from JB Chemicals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into JB Chemicals Pharmac current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in JB Chemicals Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

The JB Chemicals' current Selling General Administrative is estimated to increase to about 600 M. The JB Chemicals' current Tax Provision is estimated to increase to about 2.4 B

	2022	2023	2024	2025 (projected)
Gross Profit	27.7B	13.3B	15.2B	9.7B
Total Revenue	31.5B	34.5B	39.6B	41.6B

Gross Profit Total Revenue

JB Chemicals fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Good Will	Intangible Assets	Current Deferred Revenue
Total Assets		0.83	0.08	0.95	0.99	0.62	0.76	0.98	0.98	0.28	0.98	-0.22	0.14	0.93	0.7	0.05	0.61	0.98	0.1	-0.32	0.96	0.96	-0.85	0.58	0.96	-0.45
Short Long Term Debt Total	0.83		-0.12	0.82	0.77	0.33	0.95	0.77	0.76	0.29	0.86	-0.14	0.0	0.73	0.51	-0.09	0.83	0.74	-0.12	-0.41	0.93	0.72	-0.64	0.33	0.9	-0.43
Other Current Liab	0.08	-0.12		0.07	0.09	-0.08	-0.15	0.09	0.1	0.06	0.0	0.4	0.37	0.08	0.09	0.36	-0.07	0.06	-0.21	0.05	0.03	0.2	-0.11	-0.27	0.08	0.05
Total Current Liabilities	0.95	0.82	0.07		0.92	0.51	0.77	0.88	0.93	0.22	0.92	-0.08	0.2	0.86	0.58	0.13	0.46	0.89	0.08	-0.15	0.96	0.92	-0.77	0.44	0.91	-0.4
Total Stockholder Equity	0.99	0.77	0.09	0.92		0.66	0.69	0.98	0.98	0.29	0.97	-0.25	0.14	0.93	0.71	0.06	0.56	0.98	0.13	-0.31	0.93	0.96	-0.85	0.62	0.93	-0.45
Property Plant And Equipment Net	0.62	0.33	-0.08	0.51	0.66		0.35	0.65	0.63	0.03	0.62	-0.24	0.15	0.59	0.67	0.14	0.33	0.69	0.34	-0.22	0.5	0.59	-0.41	0.94	0.45	0.02
Net Debt	0.76	0.95	-0.15	0.77	0.69	0.35		0.71	0.7	-0.01	0.8	-0.06	-0.07	0.68	0.47	-0.07	0.8	0.69	-0.05	-0.43	0.88	0.64	-0.58	0.36	0.82	-0.26
Retained Earnings	0.98	0.77	0.09	0.88	0.98	0.65	0.71		0.98	0.26	0.96	-0.32	0.07	0.95	0.78	-0.01	0.63	0.99	0.14	-0.47	0.91	0.94	-0.9	0.65	0.93	-0.48
Accounts Payable	0.98	0.76	0.1	0.93	0.98	0.63	0.7	0.98		0.23	0.96	-0.27	0.1	0.95	0.75	0.03	0.53	0.99	0.14	-0.37	0.93	0.95	-0.9	0.61	0.93	-0.48
Cash	0.28	0.29	0.06	0.22	0.29	0.03	-0.01	0.26	0.23		0.27	-0.26	0.24	0.22	0.25	-0.06	0.27	0.23	-0.21	-0.03	0.26	0.28	-0.18	0.0	0.35	-0.56
Non Current Assets Total	0.98	0.86	0.0	0.92	0.97	0.62	0.8	0.96	0.96	0.27		-0.28	-0.01	0.93	0.67	-0.1	0.66	0.96	0.08	-0.36	0.96	0.89	-0.82	0.61	0.97	-0.48
Non Currrent Assets Other	-0.22	-0.14	0.4	-0.08	-0.25	-0.24	-0.06	-0.32	-0.27	-0.26	-0.28		0.36	-0.38	-0.34	0.45	-0.21	-0.29	0.0	0.4	-0.14	-0.12	0.35	-0.43	-0.23	0.51
Cash And Short Term Investments	0.14	0.0	0.37	0.2	0.14	0.15	-0.07	0.07	0.1	0.24	-0.01	0.36		-0.1	0.13	0.95	-0.07	0.08	-0.15	0.26	0.12	0.37	0.0	-0.07	-0.02	0.12
Net Receivables	0.93	0.73	0.08	0.86	0.93	0.59	0.68	0.95	0.95	0.22	0.93	-0.38	-0.1		0.73	-0.17	0.57	0.95	0.15	-0.46	0.88	0.85	-0.89	0.63	0.91	-0.47
Common Stock Shares Outstanding	0.7	0.51	0.09	0.58	0.71	0.67	0.47	0.78	0.75	0.25	0.67	-0.34	0.13	0.73		0.06	0.59	0.78	0.38	-0.65	0.63	0.7	-0.67	0.67	0.65	-0.28
Short Term Investments	0.05	-0.09	0.36	0.13	0.06	0.14	-0.07	-0.01	0.03	-0.06	-0.1	0.45	0.95	-0.17	0.06		-0.16	0.01	-0.09	0.28	0.04	0.29	0.06	-0.07	-0.12	0.29
Non Current Liabilities Total	0.61	0.83	-0.07	0.46	0.56	0.33	0.8	0.63	0.53	0.27	0.66	-0.21	-0.07	0.57	0.59	-0.16		0.57	-0.14	-0.69	0.69	0.49	-0.47	0.38	0.71	-0.28
Inventory	0.98	0.74	0.06	0.89	0.98	0.69	0.69	0.99	0.99	0.23	0.96	-0.29	0.08	0.95	0.78	0.01	0.57		0.23	-0.42	0.91	0.94	-0.89	0.68	0.91	-0.42
Other Current Assets	0.1	-0.12	-0.21	0.08	0.13	0.34	-0.05	0.14	0.14	-0.21	0.08	0.0	-0.15	0.15	0.38	-0.09	-0.14	0.23		-0.04	0.01	0.11	-0.08	0.36	-0.01	0.34
Other Stockholder Equity	-0.32	-0.41	0.05	-0.15	-0.31	-0.22	-0.43	-0.47	-0.37	-0.03	-0.36	0.4	0.26	-0.46	-0.65	0.28	-0.69	-0.42	-0.04		-0.34	-0.25	0.53	-0.38	-0.39	0.26
Total Liab	0.96	0.93	0.03	0.96	0.93	0.5	0.88	0.91	0.93	0.26	0.96	-0.14	0.12	0.88	0.63	0.04	0.69	0.91	0.01	-0.34		0.9	-0.79	0.46	0.97	-0.43
Total Current Assets	0.96	0.72	0.2	0.92	0.96	0.59	0.64	0.94	0.95	0.28	0.89	-0.12	0.37	0.85	0.7	0.29	0.49	0.94	0.11	-0.25	0.9		-0.83	0.5	0.87	-0.38
Common Stock	-0.85	-0.64	-0.11	-0.77	-0.85	-0.41	-0.58	-0.9	-0.9	-0.18	-0.82	0.35	0.0	-0.89	-0.67	0.06	-0.47	-0.89	-0.08	0.53	-0.79	-0.83		-0.47	-0.82	0.54
Good Will	0.58	0.33	-0.27	0.44	0.62	0.94	0.36	0.65	0.61	0.0	0.61	-0.43	-0.07	0.63	0.67	-0.07	0.38	0.68	0.36	-0.38	0.46	0.5	-0.47		0.44	-0.1
Intangible Assets	0.96	0.9	0.08	0.91	0.93	0.45	0.82	0.93	0.93	0.35	0.97	-0.23	-0.02	0.91	0.65	-0.12	0.71	0.91	-0.01	-0.39	0.97	0.87	-0.82	0.44		-0.55
Current Deferred Revenue	-0.45	-0.43	0.05	-0.4	-0.45	0.02	-0.26	-0.48	-0.48	-0.56	-0.48	0.51	0.12	-0.47	-0.28	0.29	-0.28	-0.42	0.34	0.26	-0.43	-0.38	0.54	-0.1	-0.55

Click cells to compare fundamentals

JB Chemicals Account Relationship Matchups

JB Chemicals fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	22.4B	26.1B	35.5B	39.9B	45.9B	48.2B
Short Long Term Debt Total	449.9M	545.6M	5.7B	3.8B	4.3B	4.6B
Other Current Liab	1.1B	1.1B	236.5M	1.4B	1.6B	1.0B
Total Current Liabilities	3.5B	3.8B	5.5B	8.7B	10.0B	10.5B
Total Stockholder Equity	18.1B	21.3B	24.8B	29.2B	33.6B	35.3B
Property Plant And Equipment Net	5.7B	5.7B	5.8B	6.3B	7.3B	4.5B
Net Debt	163.0M	(19.9M)	5.0B	2.9B	3.3B	3.5B
Retained Earnings	15.8B	18.4B	22.8B	25.1B	28.9B	30.3B
Accounts Payable	1.9B	2.2B	2.4B	3.6B	4.1B	4.3B
Cash	286.9M	565.4M	769.3M	882.2M	1.0B	531.0M
Non Current Assets Total	6.9B	13.3B	20.3B	21.4B	24.6B	25.8B
Non Currrent Assets Other	64.4M	177.2M	493.9M	362.8M	417.2M	396.3M
Cash And Short Term Investments	6.9B	566.5M	2.9B	4.6B	5.3B	3.3B
Net Receivables	3.9B	6.2B	5.8B	7.0B	8.1B	8.5B
Common Stock Shares Outstanding	154.6M	154.7M	156.6M	158.6M	182.4M	113.5M
Short Term Investments	6.6B	1.1M	2.2B	3.7B	4.3B	2.8B
Liabilities And Stockholders Equity	22.4B	26.1B	35.5B	39.9B	45.9B	48.2B
Non Current Liabilities Total	794.1M	850.7M	5.2B	2.0B	2.3B	1.3B
Inventory	3.5B	4.1B	4.3B	5.0B	5.8B	6.1B
Other Current Assets	5.1B	8.1B	2.3B	1.9B	2.1B	2.6B
Other Stockholder Equity	2.1B	2.8B	(807.1M)	2.7B	3.1B	3.4B
Total Liab	4.2B	4.7B	10.7B	10.7B	12.3B	12.9B
Total Current Assets	15.5B	12.7B	15.3B	18.5B	21.3B	22.4B
Accumulated Other Comprehensive Income	1.6B	2.2B	2.7B	1.3B	1.5B	1.5B
Intangible Assets	321.1M	6.7B	13.2B	13.9B	16.0B	16.8B
Current Deferred Revenue	1.1B	1.2B	1.2B	129.9M	116.9M	111.0M
Short Term Debt	398.5M	339.4M	1.7B	3.4B	4.0B	4.2B
Other Liab	648.4M	680.7M	742.7M	644.6M	741.2M	536.5M
Net Tangible Assets	14.0B	13.5B	17.2B	14.1B	16.2B	14.2B
Other Assets	105.3M	133.8M	241.6M	123.8M	142.4M	130.7M
Short Long Term Debt	326.4M	263.2M	1.7B	3.3B	3.8B	4.0B
Property Plant Equipment	5.8B	5.7B	5.7B	5.8B	6.6B	5.8B
Long Term Debt Total	12.3M	51.4M	206.2M	4.0B	4.6B	4.8B
Non Current Liabilities Other	49.3M	31.7M	25M	17M	15.3M	28.0M
Net Invested Capital	18.4B	21.6B	30.3B	32.8B	37.7B	23.2B
Cash And Equivalents	290.1M	33.9M	18.2M	269.1M	309.5M	325.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
CRM	Salesforce
CRM	Salesforce

Other Information on Investing in JBCHEPHARM Stock

Balance Sheet is a snapshot of the financial position of JB Chemicals Pharmac at a specified time, usually calculated after every quarter, six months, or one year. JB Chemicals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of JB Chemicals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which JBCHEPHARM currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

JBCHEPHARM Investments vs Dividends Paid Analysis

Investments vs Dividends Paid

Investments vs Dividends Paid Correlation Analysis

Correlation Coefficient

Investments

Dividends Paid

JB Chemicals fundamental ratios Correlations

JB Chemicals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

JB Chemicals fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in JBCHEPHARM Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 0.99	Total Assets
Inventory	+ 0.99	Retained Earnings
Inventory	+ 0.99	Accounts Payable
Retained Earnings	+ 0.98	Total Assets
Accounts Payable	+ 0.98	Total Assets
Non Current Assets Total	+ 0.98	Total Assets

Common Stock	- 0.9	Accounts Payable
Common Stock	- 0.9	Retained Earnings
Common Stock	- 0.89	Inventory
Common Stock	- 0.89	Net Receivables
Common Stock	- 0.85	Total Stockholder Equity
Common Stock	- 0.85	Total Assets